This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Mometasone furoate - Sigma Pharmaceuticals Plc

SIGMA Pharmaceuticals

Description

Prophylaxis and treatment of allergic rhinitis by intranasal administration
• Child 3–11 years: 50 mcg daily, dose into each nostril.
• Over 12 years: 100 mcg daily, increased if necessary up to 200 mcg daily, dose into each nostril. Reduce to 50 mcg daily when controlled.

Management of nasal polyps by intranasal administration
• Adult: initially 100 mcg daily for five to six weeks, dose into each nostril, then increased if necessary to 100 mcg twice daily. Consider alternative if no improvement after five to six weeks. Reduce when controlled.

Indications

For the prophylaxis of asthma.

For prophylaxis and treatment of allergic rhinitis, and nasal polyps.

Preparations Available

Spray

Sizes Available

Spray
50 mcg per dose, 140 doses

More on: Corticosteroids , Mometasone furoate , Nasal preparations , Corticosteroids